Home/Filings/4/0001209191-19-046917
4//SEC Filing

Zeidan Ryan 4

Accession 0001209191-19-046917

CIK 0001544227other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 8:38 PM ET

Size

5.6 KB

Accession

0001209191-19-046917

Insider Transaction Report

Form 4
Period: 2019-08-19
Zeidan Ryan
Chief Development Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-08-19+10,00010,000 total
    Exercise: $7.27Exp: 2029-08-18Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on August 19, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Millendo Therapeutics, Inc.

CIK 0001544227

Entity typeother

Related Parties

1
  • filerCIK 0001785724

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 8:38 PM ET
Size
5.6 KB